Adolescent cannabis use increases risk for cocaine-induced paranoia

Drug and Alcohol Dependence

Volumn 107, Issue 2-3, 2010, Pages 196-201

  Kalayasiri, Rasmon ^a   Gelernter, Joel ^b   Farrer, Lindsay ^c,d   Weiss, Roger ^e,f   Brady, Kathleen ^g   Gueorguieva, Ralitza ^b   Kranzler, Henry R ^h   Malison, Robert T ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MCLEAN HOSPITAL   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^h UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescent; Cannabis; Cocaine; Paranoia

Indexed keywords

CANNABIS; CATECHOL METHYLTRANSFERASE; COCAINE; METHIONINE; VALINE;

ADULT; ARTICLE; CANNABIS ADDICTION; COCAINE DEPENDENCE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOIA; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SIBLING;

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE FACTORS; AGE OF ONSET; CANNABIS; CATECHOL O-METHYLTRANSFERASE; COCAINE-RELATED DISORDERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; PARANOID DISORDERS; POLYMERASE CHAIN REACTION; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SIBLINGS; UNITED STATES;

CANNABIS;

EID: 77649182252     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.10.006     Document Type: Article

References (50)

1. Addiction Research Center (NIDA) Clinical manifestations of addiction, Baltimore.
2. Agrawal A., Neale M.C., Prescott C.A., Kendler KS A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol. Med. 2004, 34:1227-1237.
3. Aharonovich E., Garawi F., Bisaga A., Brooks D., Raby W.N., Rubin E., Nunes E.V., Levin FR Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: effects on outcome. Am. J. Drug Alcohol Abuse 2006, 32:629-635.
4. Arseneault L., Cannon M., Witton J., Murray R.M. Causal association between cannabis and psychosis: examination of the evidence. Br. J. Psychiatry 2004, 184:110-117.
5. Bartlett E., Hallin A., Chapman B., Angrist B. Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?. Neuropsychopharmacology 1997, 16:77-82.
6. Bilder R.M., Volavka J., Czobor P., Malhotra A.K., Kennedy J.L., Ni X., Goldman R.S., Hoptman M.J., Sheitman B., Lindenmayer J.P., Citrome L., McEvoy J.P., Kunz M., Chakos M., Cooper T.B., Lieberman J.A. Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol. Psychiatry 2002, 52:701-707.
7. Brady K.T., Lydiard R.B., Malcolm R., Ballenger J.C. Cocaine-induced psychosis. J. Clin. Psychiatry 1991, 52:509-512.
8. Caspi A., Moffitt T.E., Cannon M., McClay J., Murray R., Harrington H., Taylor A., Arseneault L., Williams B., Braithwaite A., Poulton R., Craig I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene×environment interaction. Biol. Psychiatry 2005, 57:1117-1127.
9. Chambers R.A., Krystal J.H., Self D.W. A neurobiological basis for substance abuse comorbidity in schizophrenia. Biol. Psychiatry 2001, 50:71-83.
10. Cubells J.F., Feinn R., Pearson D., Burda J., Tang Y., Farrer L.A., Gelernter J., Kranzler H.R. Rating the severity and character of transient cocaine-induced delusions and hallucinations with a new instrument, the Scale for Assessment of Positive Symptoms for Cocaine-Induced Psychosis (SAPS-CIP). Drug Alcohol Depend. 2005, 80:23-33.
11. Cubells J.F., Kranzler H.R., McCance-Katz E., Anderson G.M., Malison R.T., Price L.H., Gelernter J. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol. Psychiatry 2000, 5:56-63.
12. Degenhardt L., Hall W. Is cannabis use a contributory cause of psychosis?. Can. J. Psychiatry 2006, 51:556-565.
13. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., Gueorguieva R., Cooper T.B., Krystal J.H. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol. Psychiatry 2005, 57:594-608.
14. D'Souza D.C., Braley G., Blaise R., Vendetti M., Oliver S., Pittman B., Ranganathan M., Bhakta S., Zimolo Z., Cooper T., Perry E. Effects of haloperidol on the behavioral, subjective, cognitive, motor, and neuroendocrine effects of Delta-9-tetrahydrocannabinol in humans. Psychopharmacology (Berl) 2008, 198:587-603.
15. D'Souza D.C., Perry E., MacDougall L., Ammerman Y., Cooper T., Wu Y.T., Braley G., Gueorguieva R., Krystal J.H. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004, 29:1558-1572.
16. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., Goldman D., Weinberger D.R. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:6917-6922.
17. Fan J.B., Zhang C.S., Gu N.F., Li X.W., Sun W.W., Wang H.Y., Feng G.Y., St Clair D., He L. Catechol-O-methyltransferase gene Val/Met functional polymorphism and risk of schizophrenia: a large-scale association study plus meta-analysis. Biol. Psychiatry 2005, 57:139-144.
18. Farrer L.A., Kranzler H.R., Yu Y., Weiss R.D., Brady K.T., Anton R., Cubells J.F., Gelernter J. Association of variants in MANEA with cocaine-related behaviors. Arch. Gen. Psychiatry 2009, 66:267-274.
19. Fergusson D.M., Boden J.M., Horwood L.J. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006, 101:556-569.
20. Fergusson D.M., Horwood L.J. Does cannabis use encourage other forms of illicit drug use?. Addiction 2000, 95:505-520.
21. Fergusson D.M., Poulton R., Smith P.F., Boden J.M. Cannabis and psychosis. BMJ 2006, 332:172-175.
22. Floyd A.G., Boutros N.N., Struve F.A., Wolf E., Oliwa G.M. Risk factors for experiencing psychosis during cocaine use: a preliminary report. J. Psychiatr. Res. 2006, 40:178-182.
23. Gelernter J., Kranzler H.R., Satel S.L., Rao P.A. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 1994, 11:195-200.
24. Gelernter J., Panhuysen C., Weiss R., Brady K., Hesselbrock V., Rounsaville B., Poling J., Wilcox M., Farrer L., Kranzler H.R. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 136B:45-52.
25. Gelernter J., Panhuysen C., Wilcox M., Hesselbrock V., Rounsaville B., Poling J., Weiss R., Sonne S., Zhao H., Farrer L., Kranzler H.R. Genomewide linkage scan for opioid dependence and related traits. Am. J. Hum. Genet. 2006, 78:759-769.
26. Glatt S.J., Faraone S.V., Tsuang M.T. Association between a functional catechol-O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 2003, 160:469-476.
27. Hall W. Is cannabis use psychotogenic?. Lancet 2006, 367:193-195.
28. Henquet C., Rosa A., Krabbendam L., Papiol S., Fananas L., Drukker M., Ramaekers J.G., van Os.J. An experimental study of catechol-o-methyltransferase Val158Met moderation of delta-9-tetrahydrocannabinol-induced effects on psychosis and cognition. Neuropsychopharmacology 2006, 31:2748-2757.
29. Kalayasiri R., Kranzler H.R., Weiss R., Brady K., Gueorguieva R., Panhuysen C., Yang B.Z., Farrer L., Gelernter J., Malison R.T. Risk factors for cocaine-induced paranoia in cocaine-dependent sibling pairs. Drug Alcohol Depend. 2006, 84:77-84.
30. Kalayasiri R., Sughondhabirom A., Gueorguieva R., Coric V., Lynch W.J., Lappalainen J., Gelernter J., Cubells J.F., Malison R.T. Dopamine beta-hydroxylase gene (DbetaH) -1021C→T influences self-reported paranoia during cocaine self-administration. Biol. Psychiatry 2007, 61:1310-1313.
31. Kalayasiri R., Sughondhabirom A., Gueorguieva R., Coric V., Lynch W.J., Morgan P.T., Cubells J.F., Malison R.T. Self-reported paranoia during laboratory " binge" cocaine self-administration in humans. Pharmacol. Biochem. Behav. 2006, 83:249-256.
32. Kandel D. Stages in adolescent involvement in drug use. Science 1975, 190:912-914.
33. Kandel D.B., Yamaguchi K., Klein L.C. Testing the gateway hypothesis. Addiction 2006, 101:470-472. (Discussion 474-476).
34. Linszen D., van Amelsvoort T. Cannabis and psychosis: an update on course and biological plausible mechanisms. Curr. Opin. Psychiatry 2007, 20:116-120.
35. Miller N.S., Klahr A.L., Gold M.S., Sweeney K., Cocores J.A. The prevalence of marijuana (cannabis) use and dependence in cocaine dependence. N Y State J. Med. 1990, 90:491-492.
36. Munafo M.R., Bowes L., Clark T.G., Flint J. Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case-control studies. Mol. Psychiatry 2005, 10:765-770.
37. Muntaner C., Kumor K.M., Nagoshi C., Jaffe J.H. Intravenous cocaine infusions in humans: dose responsivity and correlations of cardiovascular vs. subjective effects. Pharmacol. Biochem. Behav. 1989, 34:697-703.
38. Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N., Iwata N. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update. Schizophr. Res. 2009, 110:140-148.
39. Pierucci-Lagha A., Gelernter J., Chan G., Arias A., Cubells J.F., Farrer L., Kranzler H.R. Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). Drug Alcohol Depend. 2007, 91:85-90.
40. Pierucci-Lagha A., Gelernter J., Feinn R., Cubells J.F., Pearson D., Pollastri A., Farrer L., Kranzler H.R. Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). Drug Alcohol Depend. 2005, 80:303-312.
41. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
42. Rosse R.B., Fay-McCarthy M., Collins J.P., Alim T.N., Deutsch S.I. The relationship between cocaine-induced paranoia and compulsive foraging: a preliminary report. Addiction 1994, 89:1097-1104.
43. Satel S.L., Southwick S.M., Gawin F.H. Clinical features of cocaine-induced paranoia. Am. J. Psychiatry 1991, 148:495-498.
44. Sherer M.A., Kumor K.M., Cone E.J., Jaffe J.H. Suspiciousness induced by four-hour intravenous infusions of cocaine. Preliminary findings. Arch. Gen. Psychiatry 1988, 45:673-677.
45. Shifman S., Bronstein M., Sternfeld M., Pisante-Shalom A., Lev-Lehman E., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Beckmann J.S., Yakir B., Risch N., Zak N.B., Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am. J. Hum. Genet. 2002, 71:1296-1302.
46. Substance Abuse and Mental Health Services Administration, 2008. Results from the 2007 National Survey on Drug Use and Health: National Findings, Office of Applied Studies, Rockville, MD.
47. Sughondhabirom A., Jain D., Gueorguieva R., Coric V., Berman R., Lynch W.J., Self D., Jatlow P., Malison R.T. A paradigm to investigate the self-regulation of cocaine administration in humans. Psychopharmacology (Berl) 2005, 180:436-446.
48. Tanda G., Pontieri F.E., Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 1997, 276:2048-2050.
49. Wonodi I., Stine O.C., Mitchell B.D., Buchanan R.W., Thaker G.K. Association between Val108/158 Met polymorphism of the COMT gene and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120B:47-50.
50. Zammit S., Spurlock G., Williams H., Norton N., Williams N., O'Donovan M.C., Owen M.J. Genotype effects of CHRNA7, CNR1 and COMT in schizophrenia: interactions with tobacco and cannabis use. Br. J. Psychiatry 2007, 191:402-407.